Sygnature Discovery Limited
Hannah Warren is a Senior Scientist at Sygnature Discovery, having progressed from Scientist to Senior Scientist 1 since joining in April 2021. Prior to this role, Hannah completed a PhD in Cellular and Molecular Physiology at the University of Liverpool, after earning a Distinction in an MRes in Biomedical Sciences and Translational Medicine. Earlier experience includes working as a Research Scientist at GeneSys Biotech Ltd, where Hannah successfully cloned and modified DNA polymerases for enzyme activity improvement and designed LAMP assays for pathogen detection. Hannah's early career involved an industrial placement at GeneSys Biotech, focusing on cloning and purifying DNA techniques. Educational background includes a BSc in Molecular and Cellular Biology from the University of Bath.
This person is not in any offices
Sygnature Discovery Limited
2 followers
Sygnature Discovery are a leading drug discovery CRO with expertise across a range of therapeutic and biological target classes. An expert partner in disciplines including Medicinal and Computational Chemistry, In Vitro and In Vivo Pharmacology, DMPK, supported by informatics.